One in five Australian children start school with a speech or language disorder.
Some children will grow out of it, but others will go on to have persistent communication difficulties.
We know that speech and language disorders arise from genetic, neurological and environmental factors. Genetic factors are thought to play a significant role to speech and language.
We have recently identified that as many as 1 in 3 children with speech apraxia may receive a genetic diagnosis for their condition.
Our Latest News
Childhood Apraxia of Speech Trial
We are trialling a new treatment for children with childhood apraxia of speech (CAS). This treatment is the drug methylphenidate (MPH), commonly known as Ritalin. We want to find out whether MPH can help improve the speech and language symptoms of CAS in children aged 6-12 years.
Hear Ms Lorraine O'Donnell, Registered Nurse and Coordinator of this trial, explain our study in this informative reel.
Proudly in partnership with
